ISSN: 1574-8855

Journal Home

Journal Guideline

Current Drug Therapy Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Drug Therapy is a journal indexed in SJR in Pharmacology (medical) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 20. It has an SJR impact factor of 0,171 and it has a best quartile of Q3. It has an SJR impact factor of 0,171.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3) Pharmacology (medical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,171

SJR Impact factor

20

H Index

38

Total Docs (Last Year)

128

Total Docs (3 years)

2424

Total Refs

87

Total Cites (3 years)

124

Citable Docs (3 years)

0.4

Cites/Doc (2 years)

63.79

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Human Psychopharmacology Q3
Current Therapeutic Research Q3
Current Therapeutic Research - Clinical and Experimental Q3
Current Cardiovascular Risk Reports Q3
Anti-Cancer Drugs Q3

Compare this journals

Aims and Scope

Best articles by citations

Effective Anticancer Drug and Food Choices Based on Polyamine Levels in Cancer Tissues

An Updated Overview of The Complex Clinical Spectrum of Tourette Syndrome

Colloidal and Pharmacological Activity of Albumin in Clinical Fluid Management:Recent Developments

Meet Our Editorial Board Member

Identification and Validation of CCR5 Antagonists from Maraviroc Analogs by Pharmacophore Modelling and 3D-QSAR Studies

Xanthan and Locust Bean Gum (from Ceratonia siliqua) Matrix Tablets for Oral Controlled Delivery of Metoprolol Tartrate

Editorial (Thematic Issue: Recent Development On Pharmaceutical Dosage Forms: Development, Applicability, Bioequivalance-Bioavailability, New Assay Methods And Their Validations)

Novel Nanocolloidal Carriers for Noninvasive Vaccine Delivery

Drug Targeting in Bronchial Asthma: Inhaled Corticosteroids Should Reach the Peripheral Airways

Will Medicinal Cannabinoids Prove to be Useful Clinically?

Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma

Outcome Measures Following Sonodynamic Photodynamic Therapy -A Case Series

SHOW MORE ARTICLES

Beta-Blocking Agents and Electroconvulsive Therapy

Meet Our Editorial Board Member:

Editorial [ Risk Benefit: Who is Responsible? ]

Editorial [Disparity in Pharmacotherapies]

Pulmonary Vaccine Delivery Systems: A Novel Approach for Immunization

Application of Nanotechnology in Pharmaceutical Formulation Design and Development

Poloxamer/Chitosan In Situ Gelling System for Ocular Delivery of Ofloxacin

Current Status of Hormone Replacement Therapy in Post Menopausal Women

Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect

Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences

Preventative and Therapeutic Potential of Lipopolysaccharide Derived from Edible Gram-Negative Bacteria to Various Diseases

Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies